Nobelpharma Co., Ltd.

  • Committed to our mission to fulfill unmet medical needs to see your smile
  • Committed to our mission to fulfill unmet medical needs to see your smile
  • Committed to our mission to fulfill unmet medical needs to see your smile

News & Press Release

  • Press Release
    At the Japan Venture Awards 2017, held by Organization for Small & Medium Enterprises and Regional Innovation, Japan on February 6, 2017, the President and CEO of Nobelpharma, Mr. Jin Shiomura, has received “the Economy, Trade and Industry Minister Prize”
  • Press Release
  • Press Release
    Marketing authorization for Foscavir®, antiviral chemothrapeutic agent, transferred to Clinigen KK
  • Press Release
    Titanium bridge (NPC-17) received orphan designation from MHLW
  • Press Release
    Received Lisence for Marketing Class 1 Medical Devices
  • Press Release
    NPC-04 (oxcarbazepine) Approved by PMDA for the Treatment of Partial Epilepsy
  • Press Release
    Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan
Page top